Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Oncothyreon CEO: Investors had ‘unrealistic expectations’
Oncothyreon CEO: Investors had ‘unrealistic expectations’
Oncothyreon CEO: Investors had ‘unrealistic expectations’
Submitted by
admin
on March 10, 2012 - 3:52pm
Source:
MarketWatch
News Tags:
cancer vaccines
Stimuvax
Oncothyreon
vaccines
Headline:
Oncothyreon CEO: Investors had ‘unrealistic expectations’
Do Not Allow Advertisers to Use My Personal information
